Abstract:Microbes employ the thioredoxin system to defend against oxidative stress and ensure correct disulfide bonding to maintain protein function. Listeria monocytogenes has been shown to encode a putative thioredoxin, TrxA, but its biological roles and underlying mechanisms remain unknown. Here, we showed that expression of L. monocytogenes TrxA is significantly induced in bacteria treated with the thiol-specific oxidizing agent, diamide. Deletion of trxA markedly compromised tolerance of the pathogen to diamide, and mainly impaired early stages of infection in human intestinal epithelial Caco-2 cells. In addition, most trxA mutant bacteria were not associated with polymerized actin, and the rare bacteria that were associated with polymerized actin displayed very short tails or clouds during infection. Deletion or constitutive overexpression of TrxA, which was regulated by SigH, severely attenuated the virulence of the pathogen. Transcriptome analysis of L. monocytogenes revealed over 270 genes that were differentially transcribed in the ΔtrxA mutant compared to the wild-type, especially for the virulence-associated genes plcA, mpl, hly, actA, and plcB. Particularly, deletion of TrxA completely reduced LLO expression, and thereby led to a thoroughly impaired hemolytic activity. Expression of these virulence factors are positively regulated by the master regulator PrfA that was found here to use TrxA to maintain its reduced forms for activation. Interestingly, the trxA deletion mutant completely lacked flagella and was non-motile. We further confirmed that this deficiency is attributable to TrxA in maintaining the reduced intracellular monomer status of MogR, the key regulator for flagellar formation, to ensure correct dimerization. In summary, we demonstrated for the first time that L. monocytogenes thioredoxin A as a vital cellular reductase is essential for maintaining a highly reducing environment in the bacterial cytosol, which provides a favorable condition for protein folding and activation, and therefore contributes to bacterial virulence and motility.

Thioredoxin 80-activated-monocytes (TAMs) inhibit the replication of intracellular pathogens

Thioredoxin A is Essential for Motility and Contributes to Host Infection of Listeria Monocytogenes Via Redox Interactions

Endothelial-specific Expression of Mitochondrial Thioredoxin Improves Endothelial Cell Function and Reduces Atherosclerotic Lesions.

Thioredoxin Reductase from Toxoplasma Gondii: an Essential Virulence Effector with Antioxidant Function

Synthesis and Molecular Recognition Studies on Small-Molecule Inhibitors for Thioredoxin Reductase

Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actions

Trim30 Alpha Negatively Regulates Tlr-Mediated Nf-Kappa B Activation By Targeting Tab2 And Tab3 For Degradation

Lipopolysaccharide Inhibits Thioredoxin Activity in Vitro and in Vivo

Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics

The Role of Thioredoxin-1 in Suppression Sepsis Through Inhibiting Mitochondrial-Induced Apoptosis in Spleen.

CsTrx80, a Truncated Form of Thioredoxin, Possesses Chemokine-Like Property and Enhances the Immune Defense of Cynoglossus Semilaevis Against Bacterial Infection

Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages

Trx4, a novel thioredoxin protein, is important for Toxoplasma gondii fitness

Suppression of the TRIF‐dependent signaling pathway of TLRs by epoxomicin

Mtorc1-Activated Monocytes Increase Tregs and Inhibit the Immune Response to Bacterial Infections.

Thioredoxin is a metabolic rheostat controlling regulatory B cells

Reactivation of Tuberculosis by Tumor Necrosis Factor Neutralization.

A Toxoplasma gondii thioredoxin with cell adhesion and antioxidant function

Dominant-negative Tumor Necrosis Factor Protects from Mycobacterium Bovis Bacillus Calmette Guérin (BCG) and Endotoxin-Induced Liver Injury Without Compromising Host Immunity to BCG and Mycobacterium Tuberculosis.

Thioredoxin 1 Downregulates MCP-1 Secretion and Expression in Human Endothelial Cells by Suppressing Nuclear Translocation of Activator Protein 1 and Redox Factor-1.

Tnf in Host Resistance to Tuberculosis Infection